• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Upregulation of fibronectin and its integrin receptors - an adaptation to isolation stress that facilitates tumor initiation.纤维连接蛋白及其整合素受体的上调——一种适应隔离应激的机制,促进肿瘤起始。
J Cell Sci. 2023 Oct 15;136(20). doi: 10.1242/jcs.261483. Epub 2023 Oct 23.
2
Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation.胰腺癌细胞在隔离应激下上调 LPAR4,以促进富含细胞外基质的生态位并支持肿瘤起始。
Nat Cell Biol. 2023 Feb;25(2):309-322. doi: 10.1038/s41556-022-01055-y. Epub 2023 Jan 16.
3
Fibronectin-mediated upregulation of α5β1 integrin and cell adhesion during differentiation of mouse embryonic stem cells.纤维连接蛋白介导的α5β1 整合素上调和细胞黏附在小鼠胚胎干细胞分化过程中。
Cell Adh Migr. 2011 Jan-Feb;5(1):73-82. doi: 10.4161/cam.5.1.13704. Epub 2011 Jan 1.
4
Accessibility to the fibronectin synergy site in a 3D matrix regulates engagement of alpha5beta1 versus alphavbeta3 integrin receptors.在三维基质中对纤连蛋白协同位点的可及性调节α5β1与αvβ3整合素受体的结合。
Cell Commun Adhes. 2006 Sep-Dec;13(5-6):267-77. doi: 10.1080/15419060601072215.
5
Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions.α5β1 和 αvβ3 整合素在体外条件下与纤维连接蛋白相互作用的前列腺癌细胞黏附和铺展动力学中的作用。
Cell Biol Int. 2012 Oct 1;36(10):883-92. doi: 10.1042/CBI20110522.
6
The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis.纤连蛋白结合整合素α5β1和αvβ3对RhoA-GTP负载、细胞基质黏附的组织以及纤连蛋白纤维形成有不同的调节作用。
J Cell Biol. 2002 Dec 23;159(6):1071-86. doi: 10.1083/jcb.200205014. Epub 2002 Dec 16.
7
Substrate engagement of integrins α5β1 and αvβ3 is necessary, but not sufficient, for high directional persistence in migration on fibronectin.整合素α5β1和αvβ3与底物的结合对于在纤连蛋白上迁移时的高定向持续性是必要的,但并不充分。
Sci Rep. 2016 Mar 18;6:23258. doi: 10.1038/srep23258.
8
Alpha5beta1 integrin mediates strong tissue cohesion.α5β1整合素介导强大的组织黏附。
J Cell Sci. 2003 Jan 15;116(Pt 2):377-86. doi: 10.1242/jcs.00231.
9
Upregulation of fibronectin and the α5β1 and αvβ3 integrins on blood vessels within the cerebral ischemic penumbra.脑缺血半影区内血管纤维连接蛋白和α5β1、αvβ3 整合素的上调。
Exp Neurol. 2012 Jan;233(1):283-91. doi: 10.1016/j.expneurol.2011.10.017. Epub 2011 Oct 28.
10
De novo expression of the integrin alpha5beta1 regulates alphavbeta3-mediated adhesion and migration on fibrinogen.整合素α5β1的从头表达调节αvβ3介导的在纤维蛋白原上的黏附与迁移。
J Biol Chem. 2003 Jun 13;278(24):21878-85. doi: 10.1074/jbc.M212538200. Epub 2003 Apr 3.

引用本文的文献

1
pH-sensitive fibronectin nanogels combined with UTMD for anti-atherosclerosis treatment through anti-inflammatory and antioxidant effects.pH敏感型纤连蛋白纳米凝胶联合超声靶向微泡破坏技术通过抗炎和抗氧化作用用于抗动脉粥样硬化治疗
Mater Today Bio. 2025 Jul 8;33:102044. doi: 10.1016/j.mtbio.2025.102044. eCollection 2025 Aug.
2
Fibronectin Fibers Progressively Lose Their Tension in Invasive Human Breast Carcinoma while Being Tensed in DCIS and Healthy Breast Tissue.纤连蛋白纤维在浸润性人类乳腺癌中逐渐失去张力,而在导管原位癌和健康乳腺组织中则处于张力状态。
Adv Sci (Weinh). 2025 Aug;12(31):e04351. doi: 10.1002/advs.202404351. Epub 2025 Jun 5.
3
c-Rel drives pancreatic cancer metastasis through Fibronectin-Integrin signaling-induced isolation stress resistance and EMT activation.c-Rel通过纤连蛋白-整合素信号诱导的隔离应激抗性和上皮-间质转化激活驱动胰腺癌转移。
bioRxiv. 2025 Feb 1:2025.01.29.635445. doi: 10.1101/2025.01.29.635445.
4
Targeting Pancreatic Cancer Cell Stemness by Blocking Fibronectin-Binding Integrins on Cancer-Associated Fibroblasts.通过阻断癌症相关成纤维细胞上的纤连蛋白结合整合素来靶向胰腺癌干细胞特性
Cancer Res Commun. 2025 Jan 1;5(1):195-208. doi: 10.1158/2767-9764.CRC-24-0491.
5
Integrins in cancer stem cells.癌症干细胞中的整合素
Front Cell Dev Biol. 2024 Aug 21;12:1434378. doi: 10.3389/fcell.2024.1434378. eCollection 2024.
6
The Emerging Role of LPA as an Oncometabolite.LPA 作为一种致癌代谢物的新兴作用。
Cells. 2024 Apr 4;13(7):629. doi: 10.3390/cells13070629.

本文引用的文献

1
Tumor-initiating cells establish a niche to overcome isolation stress.肿瘤起始细胞建立小生境以克服隔离应激。
Trends Cell Biol. 2024 May;34(5):380-387. doi: 10.1016/j.tcb.2023.08.001. Epub 2023 Aug 26.
2
Drug-induced oxidative stress in cancer treatments: Angel or devil?药物诱导的癌症治疗中的氧化应激:天使还是魔鬼?
Redox Biol. 2023 Jul;63:102754. doi: 10.1016/j.redox.2023.102754. Epub 2023 May 18.
3
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth.不断演变的肿瘤微环境:从癌症起始到转移灶生长
Cancer Cell. 2023 Mar 13;41(3):374-403. doi: 10.1016/j.ccell.2023.02.016.
4
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.肿瘤进展和免疫逃逸中的细胞外基质重塑:从机制到治疗。
Mol Cancer. 2023 Mar 11;22(1):48. doi: 10.1186/s12943-023-01744-8.
5
Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation.胰腺癌细胞在隔离应激下上调 LPAR4,以促进富含细胞外基质的生态位并支持肿瘤起始。
Nat Cell Biol. 2023 Feb;25(2):309-322. doi: 10.1038/s41556-022-01055-y. Epub 2023 Jan 16.
6
Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis.肿瘤微环境丰富了干性特征:治疗抵抗和转移的结构事件。
Mol Cancer. 2022 Dec 22;21(1):225. doi: 10.1186/s12943-022-01682-x.
7
Integrin-mediated cancer progression as a specific target in clinical therapy.整合素介导的癌症进展作为临床治疗的特定靶点。
Biomed Pharmacother. 2022 Nov;155:113745. doi: 10.1016/j.biopha.2022.113745. Epub 2022 Sep 28.
8
New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance.DDR1胶原蛋白受体在肿瘤休眠、免疫排斥和治疗抗性中的新功能。
Front Oncol. 2022 Jul 22;12:956926. doi: 10.3389/fonc.2022.956926. eCollection 2022.
9
Ligand-independent integrin β1 signaling supports lung adenocarcinoma development.配体非依赖型整合素β1 信号通路支持肺腺癌的发展。
JCI Insight. 2022 Aug 8;7(15):e154098. doi: 10.1172/jci.insight.154098.
10
QR code model: a new possibility for GPCR phosphorylation recognition.二维码模型:GPCR 磷酸化识别的新可能。
Cell Commun Signal. 2022 Mar 2;20(1):23. doi: 10.1186/s12964-022-00832-4.

纤维连接蛋白及其整合素受体的上调——一种适应隔离应激的机制,促进肿瘤起始。

Upregulation of fibronectin and its integrin receptors - an adaptation to isolation stress that facilitates tumor initiation.

机构信息

Department of Pathology, Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.

Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA 92037, USA.

出版信息

J Cell Sci. 2023 Oct 15;136(20). doi: 10.1242/jcs.261483. Epub 2023 Oct 23.

DOI:10.1242/jcs.261483
PMID:37870164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10652044/
Abstract

Tumor initiation at either primary or metastatic sites is an inefficient process in which tumor cells must fulfill a series of conditions. One critical condition involves the ability of individual tumor-initiating cells to overcome 'isolation stress', enabling them to survive within harsh isolating microenvironments that can feature nutrient stress, hypoxia, oxidative stress and the absence of a proper extracellular matrix (ECM). In response to isolation stress, tumor cells can exploit various adaptive strategies to develop stress tolerance and gain stemness features. In this Opinion, we discuss how strategies such as the induction of certain cell surface receptors and deposition of ECM proteins enable tumor cells to endure isolation stress, thereby gaining tumor-initiating potential. As examples, we highlight recent findings from our group demonstrating how exposure of tumor cells to isolation stress upregulates the G-protein-coupled receptor lysophosphatidic acid receptor 4 (LPAR4), its downstream target fibronectin and two fibronectin-binding integrins, α5β1 and αvβ3. These responses create a fibronectin-rich niche for tumor cells, ultimately driving stress tolerance, cancer stemness and tumor initiation. We suggest that approaches to prevent cancer cells from adapting to stress by suppressing LPAR4 induction, blocking its downstream signaling or disrupting fibronectin-integrin interactions hold promise as potential strategies for cancer treatment.

摘要

肿瘤起始于原发性或转移性部位是一个效率低下的过程,其中肿瘤细胞必须满足一系列条件。一个关键条件涉及到单个肿瘤起始细胞克服“隔离应激”的能力,使它们能够在恶劣的隔离微环境中存活,这些微环境的特点是营养应激、缺氧、氧化应激和缺乏适当的细胞外基质(ECM)。为了应对隔离应激,肿瘤细胞可以利用各种适应性策略来发展应激耐受和获得干性特征。在本观点中,我们讨论了诱导某些细胞表面受体和 ECM 蛋白沉积等策略如何使肿瘤细胞能够耐受隔离应激,从而获得肿瘤起始潜能。作为例子,我们强调了我们小组最近的发现,即肿瘤细胞暴露于隔离应激会上调 G 蛋白偶联受体溶血磷脂酸受体 4(LPAR4)、其下游靶标纤维连接蛋白以及两个纤维连接蛋白结合整联蛋白 α5β1 和 αvβ3。这些反应为肿瘤细胞创造了富含纤维连接蛋白的生态位,最终导致应激耐受、癌症干性和肿瘤起始。我们认为,通过抑制 LPAR4 的诱导、阻断其下游信号或破坏纤维连接蛋白-整联蛋白相互作用来防止肿瘤细胞适应应激的方法可能成为癌症治疗的潜在策略。